Colonic motility in ulcerative colitis

United European Gastroenterology Journal

Volumn 2, Issue 6, 2014, Pages 457-462

  Bassotti, Gabrio ^a   Antonelli, Elisabetta ^b   Villanacci, Vincenzo ^c   Baldoni, Monia ^a   Dore, Maria Pina ^d,e  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Perugia General Hospital   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Colon; Enteric nervous system; Inflammation; Manometry; Motility; Myenteric plexus; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1BETA; NEUROKININ 2 RECEPTOR; NEUROTENSIN; NICOTINE; NITRIC OXIDE; SUBSTANCE P; TACHYKININ;

BARIUM ENEMA; CATHETER; COLON MOTILITY; DIARRHEA; ELECTRON MICROSCOPY; GASTROINTESTINAL MOTILITY DISORDER; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MUSCLE CONTRACTILITY; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; TELEMETRY; ULCERATIVE COLITIS;

EID: 85006226852     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640614548096     Document Type: Review

References (48)

1. Bassotti G, Germani U and Morelli A. Human colonic motility: physiological aspects. Int J Colorectal Dis 1995; 10: 173–180.
2. Bassotti G, Iantorno G, Fiorella S, et al. Colonic motility in man: features in normal subjects and in patients with chronic idiopathic constipation. Am J Gastroenterol 1999; 94: 1760–1770.
3. Bassotti G, Gaburri M, Imbimbo BP, et al. Distensionstimulated propagated contractions in human colon. Dig Dis Sci 1994; 39: 1955–1960.
4. Lakhan SE and Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflammation 2010; 7: 37.
5. Moynes DM, Lucas GH, Beyak MJ, et al. Effects of inflammation on the innervation of the colon. Toxicol Pathol 2014; 42: 111–117.
6. Ordas I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet 2012; 380: 1606–1619.
7. Spriggs EA, Code CF, Bargen JA, et al. Motility of the pelvic colon and rectum of normal persons and patients with ulcerative colitis. Gastroenterology 1951; 19: 480–491.
8. Kern F Jr, Almy TP, Abbot FK, et al. The motility of the distal colon in nonspecific ulcerative colitis. Gastroenterology 1951; 19: 492–503.
9. Chaudary NA and Truelove SC. Human colonic motility: a comparative study of normal subjects, patients with ulcerative colitis, and patients with the irritable colon syndrome. I. Resting patterns of motility. Gastroenterology 1961; 40: 1–17.
10. Jalan KN, Walker RJ, Prescott RJ, et al. Faecal stasis and diverticular disease in ulcerative colitis. Gut 1970; 11: 688–696.
11. Rao SS and Read NW. Gastrointestinal motility in patients with ulcerative colitis. Scand J Gastroenterol 1990; 172(suppl): 22–28.
12. Snape WJ Jr, Matarazzo SA and Cohen S. Abnormal gastrocolonic response in patients with ulcerative colitis. Gut 1980; 21: 392–396.
13. Snape WJ Jr and Kao HW. Role of inflammatory mediators in colonic smooth muscle function in ulcerative colitis. Dig Dis Sci 1988; 33(3 Suppl): 65S–70S.
14. Bassotti G, Imbimbo BP, Gaburri M, et al. Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide. Digestion 1987; 37: 59–64.
15. Reddy SN, Bazzocchi G, Chan S, et al. Colonic motility and transit in health and ulcerative colitis. Gastroenterology 1991; 101: 1289–1297.
16. Sethi AK and Sarna SK. Colonic motor activity in acute colitis in conscious dogs. Gastroenterology 1991; 100: 954–963.
17. Sethi AK and Sarna SK. Colonic motor response to a meal in acute colitis. Gastroenterology 1991; 101: 1537–1546.
18. Lunney PC and Leong RW. Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 2012; 36: 997–1008.
19. Green JT, McKirdy HC, Rhodes J, et al. Intra-luminal nicotine reduces smooth muscle tone and contractile activity in the distal large bowel. Eur J Gastroenterol Hepatol 1999; 11: 1299–1304.
20. Coulie B, Camilleri M, Bharucha AE, et al. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol Ther 2001; 15: 653–663.
21. Bassotti G, de Roberto G, Chistolini F, et al. Twentyfour-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. Int J Colorectal Dis 2004; 19: 493–497.
22. Bassotti G, Villanacci V, Mazzocchi A, et al. Colonic propulsive and postprandial motor activity in patients with ulcerative colitis in remission. Eur J Gastroenterol Hepatol 2006; 18: 507–510.
23. Boughton-Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn’s disease. Lancet 1993; 342: 338–340.
24. Godkin AJ, De Belder AJ, Villa L, et al. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996; 26: 867–872.
25. Mourelle M, Casellas F, Guarner F, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology 1995; 109: 1497–1502.
26. Tomita R and Tanjoh K. Role of nitric oxide in the colon of patients with ulcerative colitis. World J Surg 1998; 22: 88–91.
27. Tomita R, Munakata K and Tanjoh K. Role of nonadrenergic non-cholinergic inhibitory nerves in the colon of patients with ulcerative colitis. J Gastroenterol 1998; 33: 48–52.
28. Tomita R, Tanjoh K, Fujisaki S, et al. Peptidergic nerves in the colon of patients with ulcerative colitis. Hepatogastroenterology 2000; 47: 400–404.
29. Al-Saffar A and Hellstro¨m PM. Contractile responses to natural tachykinins and selective tachykinin analogs in normal and inflamed ileal and colonic muscle. Scand J Gastroenterol 2001; 36: 485–493.
30. Smith AS and Smid SD. Impaired capsaicin and neurokinin- evoked colonic motility in inflammatory bowel disease. J Gastroenterol Hepatol 2005; 20: 697–704.
31. Cao W, Vrees MD, Kirber MT, et al. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2004; 286: G833–G843.
32. Vrees MD, Pricolo VE, Potenti FM, et al. Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines. Arch Surg 2002; 137: 439–445.
33. Ter Beek WP, Muller ES, van den Berg M, et al. Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine. Inflamm Bowel Dis 2008; 14: 612–619.
34. Bernardini N, Ippolito C, Segnani C, et al. Histopathology in gastrointestinal neuromuscular diseases: methodological and ontological issues. Adv Anat Pathol 2013; 20: 17–31.
35. Rumessen JJ. Ultrastructure of interstitial cells of Cajal at the colonic submuscular border in patients with ulcerative colitis. Gastroenterology 1996; 111: 1447–1455.
36. Rumessen JJ, Vanderwinden JM and Horn T. Ulcerative colitis: ultrastructure of interstitial cells in myenteric plexus. Ultrastruct Pathol 2010; 34: 279–287.
37. Roberts PJ, Morgan K, Miller R, et al. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 2001; 48: 468–472.
38. Stoyanova II and Gulubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem 2002; 104: 185–192.
39. Neunlist M, Aubert P, Toquet C, et al. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut 2003; 52: 84–90.
40. Ohama T, Hori M, Fujisawa M, et al. Downregulation of CPI-17 contributes to dysfunctional motility in chronic intestinal inflammation model mice and ulcerative colitis patients. J Gastroenterol 2008; 43: 858–865.
41. von Boyen GB, Schulte N, Pfluger C, et al. Distribution of enteric glia and GDNF during gut inflammation. BMC Gastroenterol 2011; 11: 3.
42. Bassotti G, Villanacci V, Nascimbeni R, et al. Enteric neuroglial apoptosis in inflammatory bowel diseases. J Crohns Colitis 2009; 3: 264–270.
43. Villanacci V, Bassotti G, Nascimbeni R, et al. Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil 2008; 20: 1009–1016.
44. Smyth CM, Akasheh N, Woods S, et al. Activated eosinophils in association with enteric nerves in inflammatory bowel disease. PLoS One 2013; 8: e64216.
45. Greig E and Sanale GI. Diarrhea in ulcerative colitis. The role of altered colonic sodium transport. Ann N Y Acad Sci 2000; 915: 327–332.
46. Chey WD and Cash BD. Irritable bowel syndrome: update on colonic neuromuscular dysfunction and treatment. Curr Gastroenterol Rep 2006; 8: 273–281.
47. Bassotti G and Villanacci V. Colonic diverticular disease: abnormalities of neuromuscular function. Dig Dis 2012; 30: 24–28.
48. Bassotti G, Villanacci V, Antonelli E, et al. Enteric glial cells: new players in gastrointestinal motility? Lab Invest 2007; 87: 628–632.